US 7,569,385 B2
	Multipotent amniotic fetal stem cells
Martin Haas, San Diego, Calif. (US)
Assigned to The Regents of the University of California, Oakland, Calif. (US)
Filed on Aug. 13, 2004, as Appl. No. 10/918,739.
Claims priority of provisional application 60/495513, filed on Aug. 14, 2003.
Claims priority of provisional application 60/495437, filed on Aug. 14, 2003.
Prior Publication US 2005/0054093 A1, Mar. 10, 2005
Int. Cl. C12N 5/00 (2006.01); C12N 5/06 (2006.01); C12N 5/10 (2006.01)

U.S. Cl. 435—325  [435/402; 435/455]

12 Claims

1. A composition comprising isolated, mortal, epithelioid multipotent stem cells derived from amniotic fluid, wherein said stem cells are characterized by expression of SSEA3, SSEA4, Tra1-60, Tra1-81, Tra2-54, Oct-4 and CD105, and by less than 5% expression of SSEA1.